Abstract:Background Neuropilin - 2 ( NRP2) is a high-affinity kinase-deficient receptor for vascular endothelial growth factor ( VEGF) and semaphorin 3F. We investigated its function in human colorectal cancers.Methods Immunohistochemistry and immunoblotting were used to assess NRP2 expression levels in colorectal tumors and colorectal cancer cell lines, respectively. HCT-116 colorectal cancer cells stably transfected with short hairpin RNA ( shRNAs) against NRP2 or control shRNAs were assayed for proliferation by the tetrazolium salt 3-( 4,5-dimethylthiazol-2-yl)- 2,5- diphenyltetrazolium bromide ( MTT) assay and for activation of the VEGFR1 pathway by immuno blotting. Soft agar assays, Annexin V staining, and Boyden chamber assays were used to examine anchorage-independent growth, apoptosis in response to hypoxia, and cell migration/ invasion, respectively, in HCT-116 transfectants. Tumor growth and metastasis were analyzed in mice ( groups of 10) injected with shRNA-expressing HCT-116 cells. The effect of in vivo targeting of NRP2 by small interfering RNA ( siRNA) on the growth of hepatic colorectal tumors derived from luciferase-expressing HCT-116 cells was assessed by measuring changes in bioluminescence and final tumor volumes. All statistical tests were two-sided.Results NRP2 expression was substantially higher in tumors than in adjacent mucosa. HCT-116 transfectants with reduced NRP2 levels had reduced VEGFR1 signaling, but proliferation was unchanged. Anchorage-independent growth, survival under hypoxic conditions, and motility/ invasiveness were also reduced. In vivo, HCT-116 transfectants with reduced NRP2 demonstrated decreased tumor growth, fewer metastases, and increased apoptosis compared with control cells. Hepatic colorectal tumors in mice treated with NRP2 siRNAs were statistically significantly smaller than those in mice treated with control siRNAs ( at 28 days after implantation, mean control siRNAs = 420 mm(3), mean NRP2 siRNAs = 36 mm(3), NRP2 vs control: difference = 385 mm(3), 95% confidence interval = 174 mm(3) to 595 mm(3), P =.005).Conclusion NRP2 on colorectal carcinoma cells is important for tumor growth and is a potential therapeutic target in human cancers where it is expressed.

Neuropilin-2 Mediated Β-Catenin Signaling and Survival in Human Gastro-Intestinal Cancer Cell Lines.

Abstract #1989: Down-regulation of Neuropilin-2 Suppresses in Vivo Growth of Gastric Cancer and Sensitizes Cells to 5Fu-Induced Apoptosis

Neuropilin-2–Mediated Tumor Growth and Angiogenesis in Pancreatic Adenocarcinoma

Neuropilin-2 is Involved in Tumor Growth and Angiogenesis of Pancreatic Adenocarcinoma

Therapeutic Targeting of Neuropilin-2 on Colorectal Carcinoma Cells Implanted in the Murine Liver

Identification of Cancer Stem Cells in Human Gastrointestinal Carcinoid and Neuroendocrine Tumors.

Neuropilin 2 and soluble neuropilin 2 in neuroendocrine neoplasms

Data from Neuropilin-2 Promotes Extravasation and Metastasis by Interacting with Endothelial Α5 Integrin

NRSN2 Promotes Non-Small Cell Lung Cancer Cell Growth Through PI3K/Akt/mTOR Pathway.

Cytoplasmic neuropilin 2 is associated with metastasis and a poor prognosis in early tongue cancer patients

N-myc Downstream Regulated Gene 1 Inhibition of Tumor Progression in Caco2 Cells.

Neuropilin-2-expressing Breast Cancer Cells Mitigate Radiation-Induced Oxidative Stress Through Nitric Oxide Signaling.

Neuropilin-2 expressing cells in breast cancer are S-nitrosylation hubs that mitigate radiation-induced oxidative stress

[Expression of Neuropilin 2 in Human Colorectal Carcinoma and Its Correlation with Lymphangiogenesis and Lymphatic Metastasis of Tumor].

Supplementary Figure 1 from Neuropilin-2 Promotes Extravasation and Metastasis by Interacting with Endothelial Α5 Integrin

Neuropilin-1 Expression Associates with Poor Prognosis in HNSCC and Elicits EGFR Activation upon CDDP-Induced Cytotoxic Stress

Neuropilin 1 Expression Correlates with the Radio-resistance of Human Non-Small-cell Lung Cancer Cells

Targeting neuropilin-1 interactions is a promising anti-tumor strategy

Anti-neuropilin-1 monoclonal antibody suppresses the migration and invasion of human gastric cancer cells via Akt dephosphorylation.

N2E4, a Monoclonal Antibody Targeting Neuropilin-2, Inhibits Tumor Growth and Metastasis in Pancreatic Ductal Adenocarcinoma via Suppressing FAK/Erk/HIF-1α Signaling

Underexpressed CNDP2 Participates in Gastric Cancer Growth Inhibition Through Activating the MAPK Signaling Pathway